FIELD: oncology and immunology. SUBSTANCE: ferrocene compound-based preparations with nitrogen-containing components are administered orally, intravenously, intramuscularly, immediately on tumor, or externally in dose between 3 and 50 mg (based on active substance) 1 to 3 times daily for 30-60 days. EFFECT: eliminated complications and increased efficiency. 6 cl, 1 dwg, 7 ex
Authors
Dates
1999-06-10—Published
1998-11-12—Filed